| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2009: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2008: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
|
|---|
| Research Abstract |
In the present study, we detected a case of primary pulmonary adenocarcinoma with an immunohistochemically proven ALK abnormality. The tumor showed an endobronchial polypoid growth pattern with peripheral pulmonary tissue invasion. Recently, lung cancers having ALK gene abnormalities have attracted growing attention because of therapeutic aspects, i.e., ALK inhibitor therapies. The present case is the first case of ALK-immunopositive lung cancer suggesting central bronchial surface epithelial origin.
|
